Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. ACN
6. III
7. SAN
8. TTEC
9. SNY
10. DAL

Go back to Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome
(NASDAQ: MDCX) Delayed: 0.46 +0.11 (31.43%)
Previous Close $0.35    52 Week High $ 
Open $0.36    52 Week Low $ 
Day High $0.48    P/E N/A 
Day Low $0.36    EPS $ 
Volume 12,185,101